Groupe la Francaise lifted its holdings in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 352.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,725 shares of the scientific and technical instruments company's stock after acquiring an additional 27,829 shares during the quarter. Groupe la Francaise owned about 0.08% of Itron worth $3,762,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Janney Montgomery Scott LLC lifted its holdings in shares of Itron by 0.7% during the 1st quarter. Janney Montgomery Scott LLC now owns 16,795 shares of the scientific and technical instruments company's stock valued at $1,759,000 after acquiring an additional 121 shares in the last quarter. CoreCap Advisors LLC lifted its holdings in shares of Itron by 25.5% during the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock valued at $67,000 after acquiring an additional 125 shares in the last quarter. Captrust Financial Advisors lifted its holdings in shares of Itron by 6.3% during the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock valued at $233,000 after acquiring an additional 128 shares in the last quarter. HighTower Advisors LLC lifted its holdings in Itron by 2.0% in the 1st quarter. HighTower Advisors LLC now owns 7,501 shares of the scientific and technical instruments company's stock worth $786,000 after buying an additional 146 shares in the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC lifted its holdings in Itron by 7.3% in the 1st quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,345 shares of the scientific and technical instruments company's stock worth $246,000 after buying an additional 160 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.
Itron Stock Performance
NASDAQ:ITRI traded down $0.13 during trading hours on Wednesday, reaching $123.93. 572,189 shares of the stock were exchanged, compared to its average volume of 590,617. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The firm has a 50 day simple moving average of $130.54 and a 200-day simple moving average of $115.46. Itron, Inc. has a 52 week low of $90.11 and a 52 week high of $140.04. The stock has a market capitalization of $5.67 billion, a P/E ratio of 21.18, a P/E/G ratio of 0.68 and a beta of 1.35.
Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company had revenue of $606.76 million for the quarter, compared to the consensus estimate of $610.36 million. During the same quarter last year, the business posted $1.21 EPS. Itron's quarterly revenue was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, sell-side analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.
Insider Activity at Itron
In related news, CFO Joan S. Hooper sold 970 shares of the business's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $121,550.70. Following the completion of the sale, the chief financial officer owned 88,394 shares of the company's stock, valued at $11,076,652.14. This represents a 1.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP John F. Marcolini sold 3,783 shares of the business's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $116.73, for a total transaction of $441,589.59. Following the sale, the senior vice president directly owned 21,865 shares of the company's stock, valued at approximately $2,552,301.45. This represents a 14.75% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,856 shares of company stock worth $1,922,470 over the last quarter. 1.51% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of equities analysts have commented on ITRI shares. TD Cowen boosted their price objective on shares of Itron from $139.00 to $145.00 and gave the stock a "buy" rating in a report on Friday, June 20th. Stephens set a $130.00 price objective on shares of Itron in a report on Monday, August 4th. Piper Sandler cut their price objective on shares of Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a report on Monday, May 5th. Johnson Rice lowered shares of Itron from a "buy" rating to an "accumulate" rating in a report on Friday, August 1st. Finally, Wall Street Zen upgraded shares of Itron from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Eleven equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $136.25.
Get Our Latest Analysis on Itron
Itron Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Further Reading

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.